• PharmaResearch CEO Ji Hoon Sohn increased his holding to 1,000 common shares, or 0.01%, as of Nov. 12, 2026.
• He purchased 500 shares on Nov. 10, 2026, at KRW 210,490 per share.
• A further 500 shares purchased on Nov. 11, 2026, cost KRW 240,192 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaResearch Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112000201), on November 12, 2026, and is solely responsible for the information contained therein.